Valens Semiconductor Ltd.·4

Jun 1, 9:14 AM ET

Boim Amir 4

4 · Valens Semiconductor Ltd. · Filed Jun 1, 2026

Research Summary

AI-generated summary of this filing

Updated

Valens (VLN) SVP Amir Boim Exercises Options and Sells Shares

What Happened
Amir Boim, SVP of Operations and PMO at Valens Semiconductor (VLN), exercised a total of 9,938 stock options (1,431 on May 28 and 8,507 on May 29, 2026) at $0.86 per share, paying $8,550 in aggregate. He then sold the 9,938 resulting shares the same dates: 1,431 shares sold at $3.50 for $5,009 (May 28) and 8,507 shares sold at $3.55 for $30,200 (May 29), for total gross proceeds of $35,209. The transactions were executed under a pre-established Rule 10b5-1 trading plan.

Key Details

  • Transaction dates and prices:
    • May 28, 2026: exercised 1,431 options @ $0.86 (cost $1,231); sold 1,431 shares @ $3.50 (proceeds $5,009).
    • May 29, 2026: exercised 8,507 options @ $0.86 (cost $7,319); sold 8,507 shares @ $3.55 (proceeds $30,200).
  • Aggregate: 9,938 options exercised for $8,550; 9,938 shares sold for $35,209.
  • Footnotes: Sales were made pursuant to a Rule 10b5-1 plan adopted Aug 11, 2025 (F1). Shares were acquired by exercising stock options and sold the same day (F2–F4). Derivative entries at $0.00 reflect the option exercises.
  • Shares owned after the transactions are not specified in the provided filing excerpt.
  • Filing timing: Form 4 was filed on June 1, 2026 and covers trades on May 28–29, 2026; the filing appears timely under Form 4 reporting rules.

Context
This was an exercise of options followed by same-day sales (a common cashless exercise pattern), and the sales were made under a 10b5-1 plan, indicating they were pre-planned rather than ad hoc insider sales. Such routine option-exercise-and-sell transactions are typically used to cover exercise costs and taxes and are less informative about an officer’s view of the company than outright open-market purchases.

Insider Transaction Report

Form 4
Period: 2026-05-28
Boim Amir
SVP, Operations and PMO
Transactions
  • Exercise/Conversion

    Ordinary Shares

    [F1][F2]
    2026-05-28$0.86/sh+1,431$1,231405,399 total
  • Sale

    Ordinary Shares

    [F1][F3]
    2026-05-28$3.50/sh1,431$5,009403,968 total
  • Exercise/Conversion

    Ordinary Shares

    [F1][F2]
    2026-05-29$0.86/sh+8,507$7,319412,475 total
  • Sale

    Ordinary Shares

    [F1][F3]
    2026-05-29$3.55/sh8,507$30,200403,968 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F4]
    2026-05-281,4318,507 total
    Exercise: $0.86From: 2020-01-11Exp: 2029-01-11Ordinary Shares (1,431 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F4]
    2026-05-298,5070 total
    Exercise: $0.86From: 2020-01-11Exp: 2029-01-11Ordinary Shares (8,507 underlying)
Footnotes (4)
  • [F1]The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2025
  • [F2]The shares were acquired upon the exercise of stock options
  • [F3]The shares sold were acquired upon the exercise of stock options on the same date
  • [F4]The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.
Signature
/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact|2026-06-01

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT